COVID-19 Health Messaging Efficacy and Its Impact on Public Perception, Anxiety, and Behavior

Sponsor
Milton S. Hershey Medical Center (Other)
Overall Status
Completed
CT.gov ID
NCT04377581
Collaborator
The Huck Institutes of the Life Sciences (Other), The Social Science Research Institute (Other), The Department of Family and Community Medicine, Penn State College of Medicine (Other), The College of Healthcare Information Management Executives (CHIME) (Other)
18,251
1
3
6038.2

Study Details

Study Description

Brief Summary

Effective communication is a critical component of managing pandemic outbreaks like COVID-19. This study explores COVID-19 related public knowledge, perceptions, belief in public health recommendations, intent to comply with public health recommendations, trust in information sources and preferred information sources. Participants are invited to include detailed free-text answers to make sure their COVID-19 experiences are heard.

Condition or Disease Intervention/Treatment Phase

    Detailed Description

    The survey is available online in 23 languages. Free-text responses in native languages are highly encouraged. A robust global response will not only provide invaluable information to inform clinicians, healthcare institutions and governments about how to optimize the content and venue of COVID-19 messaging, but will help write a Story of COVID in the words and languages of people from all over the world.

    Study Design

    Study Type:
    Observational
    Actual Enrollment :
    18251 participants
    Observational Model:
    Ecologic or Community
    Time Perspective:
    Cross-Sectional
    Official Title:
    COVID-19 Health Messaging Efficacy and Its Impact on Public Perception, Anxiety, and Behavior
    Actual Study Start Date :
    Apr 9, 2020
    Actual Primary Completion Date :
    Jul 10, 2020
    Actual Study Completion Date :
    Jul 10, 2020

    Outcome Measures

    Primary Outcome Measures

    1. Knowledge and Confidence in Knowledge of COVID-19 [Through study completion, an average of 3 months.]

      Binary knowledge measures (true/false questions pertaining to COVID-19) each have a corresponding 5-point confidence score, the inverse of which generates a weighting variable. Weighted knowledge scores will be analyzed via a generalized linear mixed-methods effects model with a logistic link function and a random effect for the participant, generating a probability of correct response from 0 to 1.0.

    2. Beliefs about the effectiveness of public health recommendations [Through study completion, an average of 3 months.]

      Participants are asked, "Do you think that following these CDC recommendations will decrease the spread of COVID-19 in your community?" and select from a 5-point scale, Minimum: 1=certainly not; Maximum: 5 = most certainly.

    3. Intent to comply with public health recommendations [Through study completion, an average of 3 months.]

      Participants are asked, "Will you follow these recommendations?" and select from a 5-point scale, Minimum: 1=certainly not; Maximum: 5 = most certainly.

    4. Perception of Risk of COVID-19 and other health threats [Through study completion, an average of 3 months.]

      Participants are asked, "How likely is it that you will be diagnosed with any of the following diseases over the next year?" and rate their perceived likelihood of diagnosis for Measles, Flu, Lung Cancer, Ebola and COVID-19 on a 5 point scale. Minimum: 1, very unlikely; Maximum: 5, very likely. Participants are asked, "How serious do you think infection with any of the following diseases would be (or is) to your own personal health?" and rate their perceived seriousness of diagnosis for Measles, Flu, Lung Cancer, Ebola and COVID-19 on a 5 point scale. Minimum: 1, Not at all Serious; Maximum: 5, Very Serious

    5. Perceptions of trust in common health information sources [Through study completion, an average of 3 months.]

      Participants are asked the extent to which they trust common information sources: The World Health Organization, The U.S. Centers for Disease Control and Prevention, the European Commission, the participant's national government, the participant's local government, and the participant's personal healthcare provider. Participants rate on a 5 point scale. Minimum: 1, Not at all; Maximum: 2, Completely. (As these sources are not recognized in all places, participants may select "Not Applicable" in lieu of ranking.

    6. Single most trusted news source [Through study completion, an average of 3 months.]

      Participants are asked to identify their single most trusted source of news through selection from a pre-generated list or via free-text.

    Secondary Outcome Measures

    1. Intention to change consumption of news because of COVID-19 (yes/no) [Through study completion, an average of 3 months.]

      Participants are asked if COVID-19 will change how they consume news (y/n)

    2. For participants who will change their news consumption, in what way will they change? [Through study completion, an average of 3 months.]

      Participants who answer, "Yes" to Outcome 7 are asked to provide a free-text response to describe how their consumption of news will change.

    3. Secondary information sources [Through study completion, an average of 3 months.]

      Participants are asked to identify all other sources of information via selection from pre-generated menu or free-text.

    4. Concerns about COVID-19 [Through study completion, an average of 3 months.]

      Free-text response invited to describe their concerns regarding COVID-19.

    Eligibility Criteria

    Criteria

    Ages Eligible for Study:
    18 Years and Older
    Sexes Eligible for Study:
    All
    Accepts Healthy Volunteers:
    Yes
    Inclusion Criteria:
    • 18 years of age
    Exclusion Criteria:
    • Below 18 years of age

    Contacts and Locations

    Locations

    Site City State Country Postal Code
    1 Penn State College of Medicine Hershey Pennsylvania United States 17033

    Sponsors and Collaborators

    • Milton S. Hershey Medical Center
    • The Huck Institutes of the Life Sciences
    • The Social Science Research Institute
    • The Department of Family and Community Medicine, Penn State College of Medicine
    • The College of Healthcare Information Management Executives (CHIME)

    Investigators

    • Principal Investigator: Robert P Lennon, MD, JD, Penn State College of Medicine

    Study Documents (Full-Text)

    None provided.

    More Information

    Publications

    None provided.
    Responsible Party:
    Robert Lennon, Associate Professor, Family and Community Medicine, Milton S. Hershey Medical Center
    ClinicalTrials.gov Identifier:
    NCT04377581
    Other Study ID Numbers:
    • STUDY00014798
    First Posted:
    May 6, 2020
    Last Update Posted:
    Jul 16, 2020
    Last Verified:
    Jul 1, 2020
    Studies a U.S. FDA-regulated Drug Product:
    No
    Studies a U.S. FDA-regulated Device Product:
    No
    Keywords provided by Robert Lennon, Associate Professor, Family and Community Medicine, Milton S. Hershey Medical Center
    Additional relevant MeSH terms:

    Study Results

    No Results Posted as of Jul 16, 2020